DAMIAN PHARMA AG
4Patents
4Active
4Granted
42Portfolio score
Filing activity: Oct 26, 2017 → Aug 9, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10822332B2 | Aldosterone synthase inhibitor | Human Necessities | 3 | Active |
| US11447491B2 | Aldosterone synthase inhibitor | Human Necessities | 2 | Active |
| US11992479B2 | R-fadrozole for use in the treatment of aldostonerism | Human Necessities | 0 | Active |
| US12202827B2 | Aldosterone synthase inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.